Cylex Raises $18.4 Million

Cylex Inc., a Columbia, Md.-based developer of in vitro diagnostic products for measuring immune activity, has held an $18.4 million first close on its third round of VC funding.  Channel Medical Partners and Canaan Partners co-led the deal, and were joined by First Analysis and return backers Cahn Medical Technologies, Calvert Venture Fund, Chesapeake Emerging Opportunities, Early Stage Enterprises, NJTC Venture Fund, Roche Venture Fund and The Washington Dinner Club.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />